Download PDF
Thorac Cardiovasc Surg 2018; 66(02): 135-141
DOI: 10.1055/s-0037-1606597
Original Thoracic
Georg Thieme Verlag KG Stuttgart · New York

Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer

Authors

  • Waldemar Schreiner

    1   Division for Thoracic Surgery, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital, Erlangen, Germany

  • Wojciech Dudek

    1   Division for Thoracic Surgery, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital, Erlangen, Germany

  • Sebastian Lettmaier

    2   Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital, Erlangen, Germany

  • Rainer Fietkau

    2   Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital, Erlangen, Germany

  • Horia Sirbu

    1   Division for Thoracic Surgery, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital, Erlangen, Germany
Further Information

Publication History

31 May 2017

07 August 2017

Publication Date:
09 October 2017 (online)

   Permissions and Reprints All articles of this category
Preview

Abstract

Background The incidence of local failure and residual tumor after definitive chemoradiation therapy (dCRT) for locally advanced non-small-cell lung cancer remains high, irrespective of applied radiation dose (>59 Gy). So-called salvage surgery has been suggested as a feasible treatment option after failure of definitive chemoradiation for locally advanced non-small cell lung cancer (NSCLC). Experience with salvage lung surgery (SLS) is limited, and long-term survival is rarely reported. Patient selection criteria for surgical lung salvage are not defined. The aim of this study was to assess postoperative survival and perioperative morbidity/mortality to identify prognostic factors and to define patient selection criteria.

Patients and Methods Records of 13 consecutive patients with locally advanced NSCLC, who underwent SLS at a single institution between March 2011 and November 2016, were reviewed. Descriptive statistics were applied for patient characteristics and surgical and oncological outcome. Survival rates were calculated using the Kaplan–Meier method and were compared with the long-rank test.

Results All patients initially received curative-intent definitive chemoradiation with median radiation doses of 66 Gy (range 59.4–72) and concurrent platinum-based chemotherapy. Clinical tumor stage before definitive chemoradiation was IIIA in 9, IIIB in 3, IV in 1 patients. Median interval between definitive chemoradiation and salvage surgery was 6.7 months. Perioperative morbidity and 30-days-mortality was 38% and 7.7%, respectively. The median postoperative survival and estimated 5-year survival rate were 29.7 months and 46%, respectively.

Conclusion SLS in patients with locally advanced non-small cell lung surgery following dCRT is feasible, prolongs long-term survival and allows local tumor control. Selection criteria remain undefined and patients should be considered surgical candidates during multidisciplinary team conference.

Keywords

salvage surgery lung cancer - definitive chemoradiation therapy - local failure

Authors' Contributions

Waldemar Schreiner participated in the design of the study and sequence alignment, performed the statistical analysis, and drafted the manuscript. Wojciech Dudek participated in the sequence alignment and helped in drafting the manuscript. Sebastian Lettmaier conceived the study and participated in the design and coordination of the study. All authors read and approved the final manuscript.